Swiss researchers may have paved the way for easier diagnosis of vCJD, the human equivalent of BSE, according to a study reported in the scientific journal Nature . The techniques developed by Claudio Soto, and his colleagues at the SerOno Pharmaceutical Research Institute in Geneva, might effectively speed up the process which detects the fatal, brain wasting disease, and possibly even form the groundwork for a cure.